Teza Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Teza Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20,300	Closed	-$191K	–	489
2020 Q3	$191K	Sell	20,300 -2,969	-13%	-$28.2K	0.11%	302
2020 Q2	$178K	Buy	23,269 +9,559	+70%	+$73.1K	0.04%	506
2020 Q1	$85K	Buy	+13,710	New	+$121K	0.27%	103

Teza Capital Management's AMAG Position: Q4 2020 in Review

Teza Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 20,300 shares — an estimated $191K sold.

Teza Capital Management first reported a position in AMAG in Q1 2020 and held it in 3 quarters. The position peaked at $191K in Q3 2020. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

Teza Capital Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Teza Capital Management sold 20,300 AMAG Pharmaceuticals shares in Q4 2020, an estimated $191K.
Teza Capital Management first reported a position in AMAG Pharmaceuticals in Q1 2020 and held it in 3 quarters.
Teza Capital Management's AMAG Pharmaceuticals position peaked at $191K in Q3 2020.
1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Teza Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.